What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
3.41%Above 5Y avg (3.28%)
Annual Rate
JPY 96.00Paid semi-annual
Payout Ratio
50.2%Sustainable
Next Ex-Dividend
Sep 29, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
131.84BJPY
832.14M · vs all stocks (USD)
Updated Aug 20, 2026
Trailing P/E
16.47x
vs Specialty Business Services peers
Updated Aug 20, 2026
Revenue (TTM)
60.00BJPY
378.68M · vs all stocks (USD)
Updated Aug 20, 2026
Profit Margin
16.83%
vs Specialty Business Services peers
Updated Aug 20, 2026
Beta
0.8460x
vs all stocks
Updated Aug 20, 2026
52-Week Change
39.38%
vs all stocks
Updated Aug 20, 2026
Forward Annual Dividend Yield
3.41%
vs all stocks
Updated Aug 20, 2026
Market Capitalization
131.84BJPY
832.14M · vs all stocks (USD)
Updated Aug 20, 2026
Enterprise Value
173.71BJPY
1.10B · vs all stocks (USD)
Updated Aug 20, 2026
Trailing P/E
16.47x
vs Specialty Business Services peers
Updated Aug 20, 2026
Forward P/E
20.45x
vs Specialty Business Services peers
Updated Aug 20, 2026
Price to Sales (TTM)
2.76x
vs Specialty Business Services peers
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 2.2×.Updated Aug 20, 2026
Price to Book (MRQ)
2.48x
vs Specialty Business Services peers
Updated Aug 20, 2026
Enterprise to Revenue
2.90x
vs Specialty Business Services peers
Updated Aug 20, 2026
Enterprise to EBITDA
9.64x
vs Specialty Business Services peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 9.39×.Updated Aug 20, 2026
Profit Margin
16.83%
vs Specialty Business Services peers
Updated Aug 20, 2026
Operating Margin
22.91%
vs Specialty Business Services peers
Updated Aug 20, 2026
Return on Assets (TTM)
10.01%
vs Specialty Business Services peers
Updated Aug 20, 2026
Return on Equity (TTM)
15.74%
vs Specialty Business Services peers
Updated Aug 20, 2026
Revenue (TTM)
60.00BJPY
378.68M · vs all stocks (USD)
Updated Aug 20, 2026
Revenue per Share (TTM)
1.01KJPYUpdated Aug 20, 2026
Quarterly Revenue Growth
9.90%
vs Specialty Business Services peers
Updated Aug 20, 2026
Gross Profit (TTM)
22.72BJPY
143.43M · vs all stocks (USD)
Updated Aug 20, 2026
EBITDA (TTM)
18.51BJPY
116.82M · vs all stocks (USD)
Updated Aug 20, 2026
Net Income (TTM)
10.10BJPY
63.72M · vs all stocks (USD)
Updated Aug 20, 2026
Quarterly Earnings Growth (YoY)
1.40%
vs Specialty Business Services peers
Updated Aug 20, 2026
Operating Cash Flow (TTM)
7.75BJPY
48.91M · vs all stocks (USD)
Updated Aug 20, 2026
Levered Free Cash Flow (TTM)
10.06BJPY
63.49M · vs all stocks (USD)
Updated Aug 20, 2026
Forward Annual Dividend Rate
96.00JPYUpdated Aug 20, 2026
Forward Annual Dividend Yield
3.41%
vs all stocks
Updated Aug 20, 2026
Trailing Annual Dividend Rate
85.00JPYUpdated Aug 20, 2026
Trailing Annual Dividend Yield
3.02%
vs all stocks
Updated Aug 20, 2026
5-Year Average Dividend Yield
3.28%
vs all stocks
Updated Aug 20, 2026
Payout Ratio
50.24%
vs Specialty Business Services peers
Updated Aug 20, 2026
Minority Interest (Equity)
5.90BJPYFY2026 · Mar 31, 2026
Revenue
58.49BJPYFY2026 · Mar 31, 2026
Cost of Goods Sold
35.91BJPYFY2026 · Mar 31, 2026
Gross Profit
22.58BJPYFY2026 · Mar 31, 2026
Operating Income
14.11BJPY
89.04M · vs all stocks (USD)
FY2026 · Mar 31, 2026
Pre-tax Income
14.74BJPYFY2026 · Mar 31, 2026
Income Tax Expense
3.89BJPYFY2026 · Mar 31, 2026
Net Income
10.85BJPYFY2026 · Mar 31, 2026
EBIT
14.79BJPYFY2026 · Mar 31, 2026
EBITDA (Income Statement)
18.51BJPYFY2026 · Mar 31, 2026
Research & Development
1.44BJPYFY2026 · Mar 31, 2026
Selling, General & Administrative
749.00MJPYFY2026 · Mar 31, 2026
Other Operating Expenses
1.77BJPYFY2026 · Mar 31, 2026
Non-operating Interest Income
36.00MJPYFY2026 · Mar 31, 2026
Non-operating Interest Expense
44.00MJPYFY2026 · Mar 31, 2026
EPS (Basic)
169.19JPYFY2026 · Mar 31, 2026
EPS (Diluted)
169.19JPYFY2026 · Mar 31, 2026
Basic Shares Outstanding
59.46MSharesFY2026 · Mar 31, 2026
Diluted Shares Outstanding
59.46MSharesFY2026 · Mar 31, 2026
Minority Interests (P&L)
-792.00MJPYFY2026 · Mar 31, 2026
Preferred Stock Dividends
0.00JPYFY2026 · Mar 31, 2026
Operating Cash Flow
9.99BJPYFY2026 · Mar 31, 2026
Free Cash Flow
292.00MJPYFY2026 · Mar 31, 2026
Cash & Cash Equivalents (End of Period)
14.46BJPYFY2026 · Mar 31, 2026
Starting Profit (CF Statement)
14.74BJPYFY2026 · Mar 31, 2026
Other Non-cash Items
-1.04BJPYFY2026 · Mar 31, 2026
Change in Accounts Receivable (CF)
-1.93BJPYFY2026 · Mar 31, 2026
Change in Other Assets/Liabilities
-1.78BJPYFY2026 · Mar 31, 2026
Capital Expenditures
-9.70BJPYFY2026 · Mar 31, 2026
Net Intangibles (CF)
-162.00MJPYFY2026 · Mar 31, 2026
Purchase of Investments
-545.00MJPYFY2026 · Mar 31, 2026
Sale of Investments
529.00MJPYFY2026 · Mar 31, 2026
Other Investing Activity
-85.00MJPYFY2026 · Mar 31, 2026
Net Investing Cash Flow
-9.80BJPYFY2026 · Mar 31, 2026
Long-term Debt Issuance
5.26BJPYFY2026 · Mar 31, 2026
Long-term Debt Payments
-1.53BJPYFY2026 · Mar 31, 2026
Net Short-term Debt Issuance
-185.00MJPYFY2026 · Mar 31, 2026
Common Stock Repurchase
0.00JPYFY2026 · Mar 31, 2026
Common Dividends Paid
-4.46BJPYFY2026 · Mar 31, 2026
Other Financing Charges
-60.00MJPYFY2026 · Mar 31, 2026
Net Financing Cash Flow
-968.00MJPYFY2026 · Mar 31, 2026
Shares Outstanding
59.47MSharesUpdated Aug 20, 2026
Float Shares
53.47MSharesUpdated Aug 20, 2026
% Held by Insiders
6.82%
vs all stocks
Updated Aug 20, 2026
% Held by Institutions
39.18%
vs all stocks
Updated Aug 20, 2026
Total Cash (MRQ)
15.51BJPY
97.89M · vs all stocks (USD)
Updated Aug 20, 2026
Total Cash per Share (MRQ)
260.79JPYUpdated Aug 20, 2026
Total Debt (MRQ)
12.05BJPY
76.07M · vs all stocks (USD)
Updated Aug 20, 2026
Total Debt to Equity (MRQ)
0.1658x
vs Specialty Business Services peers
Updated Aug 20, 2026
Current Ratio (MRQ)
3.63x
vs Specialty Business Services peers
Updated Aug 20, 2026
Book Value per Share (MRQ)
1.12KJPYUpdated Aug 20, 2026
Total Assets
89.29BJPY
563.56M · vs all stocks (USD)
FY2026 · Mar 31, 2026
Total Current Assets
40.88BJPYFY2026 · Mar 31, 2026
Total Liabilities
16.64BJPYFY2026 · Mar 31, 2026
Total Non-current Assets
48.41BJPYFY2026 · Mar 31, 2026
Total Non-current Liabilities
6.38BJPYFY2026 · Mar 31, 2026
Total Current Liabilities
10.26BJPYFY2026 · Mar 31, 2026
Cash & Cash Equivalents
14.73BJPYFY2026 · Mar 31, 2026
Accounts Receivable
16.86BJPYFY2026 · Mar 31, 2026
Inventory
7.31BJPYFY2026 · Mar 31, 2026
Accounts Payable
1.63BJPYFY2026 · Mar 31, 2026
Short-term Debt
2.17BJPYFY2026 · Mar 31, 2026
Other Current Liabilities
629.00MJPYFY2026 · Mar 31, 2026
Long-term Debt
5.40BJPYFY2026 · Mar 31, 2026
Other Non-current Liabilities
95.00MJPYFY2026 · Mar 31, 2026
Common Stock (Book)
2.66BJPYFY2026 · Mar 31, 2026
Retained Earnings
61.27BJPYFY2026 · Mar 31, 2026
Total Shareholders' Equity
72.66BJPY
458.58M · vs all stocks (USD)
FY2026 · Mar 31, 2026
Treasury Stock
1.91BJPYFY2026 · Mar 31, 2026
52-Week Low
1.92KJPYUpdated Aug 20, 2026
52-Week High
3.46KJPYUpdated Aug 20, 2026
52-Week Change
39.38%
vs all stocks
Updated Aug 20, 2026
Beta
0.8460x
vs all stocks
Updated Aug 20, 2026
50-Day MA
3.07KJPYUpdated Aug 20, 2026
200-Day MA
2.75KJPYUpdated Aug 20, 2026
Avg 10-Day Volume
284.07KSharesUpdated Aug 20, 2026
Avg 30-Day Volume
340.77KSharesUpdated Aug 20, 2026
Diluted EPS (TTM)
169.06JPYUpdated Aug 20, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Cash on hand covers most or all of its debt, and its equity share of assets is high for its industry.
Reads
How is this stock valued?
High Retained Earnings With Profitability And Equity
Profits kept in the business fund much of what it owns, after five straight profitable years.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 7.33: safe zoneNotable
Altman Z-Score: 7.33
High earnings qualityNotable
Earnings Quality Score: 0.73
Supply Chain
Upstream position: supplies 6 industries, depends on 0Notable
Outgoing: 6.00Incoming: 0.00
Scale
Levered free cash flow is $63.49M, above the global median of $16.24MNotable